Lu J - Search Results

1

PEG10 is imperative for TGF-β1-induced epithelial‑mesenchymal transition in hepatocellular carcinoma.

Zhang M, Sui C, Dai B, Shen W, Lu J, Yang J. Zhang M, et al. Among authors: lu j. Oncol Rep. 2017 Jan;37(1):510-518. doi: 10.3892/or.2016.5282. Epub 2016 Nov 29. Oncol Rep. 2017. PMID: 28004118

2

Effects of nucleoside analogue on patients with chronic hepatitis B-associated liver failure: meta-analysis.

Xie F, Yan L, Lu J, Zheng T, Shi C, Ying J, Shen R, Yang J. Xie F, et al. Among authors: lu j. PLoS One. 2013;8(1):e54773. doi: 10.1371/journal.pone.0054773. Epub 2013 Jan 28. PLoS One. 2013. PMID: 23382964 Free PMC article.

3

[Application of total hemihepatic vascular exclusion in liver resection for patients with hepatocellular carcinoma and impaired liver function].

Sui CJ, Lu JJ, Xu F, Shen WF, Geng L, Xie F, Dai BH, Yang JM. Sui CJ, et al. Zhonghua Wai Ke Za Zhi. 2013 Apr;51(4):331-4. Zhonghua Wai Ke Za Zhi. 2013. PMID: 23895754 Chinese.

4

Overexpression of miR-218 inhibits hepatocellular carcinoma cell growth through RET.

Sui C, Xu F, Shen W, Geng L, Xie F, Dai B, Lu J, Zhang M, Yang J. Sui C, et al. Among authors: lu j. Tumour Biol. 2015 Mar;36(3):1511-8. doi: 10.1007/s13277-014-2679-1. Epub 2014 Nov 6. Tumour Biol. 2015. PMID: 25374061

5

Investigation of serum lncRNA-uc003wbd and lncRNA-AF085935 expression profile in patients with hepatocellular carcinoma and HBV.

Lu J, Xie F, Geng L, Shen W, Sui C, Yang J. Lu J, et al. Tumour Biol. 2015 May;36(5):3231-6. doi: 10.1007/s13277-014-2951-4. Epub 2014 Dec 14. Tumour Biol. 2015. PMID: 25501706

6

The treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials.

Yan L, Xie F, Lu J, Ni Q, Shi C, Tang C, Yang J. Yan L, et al. Among authors: lu j. BMC Gastroenterol. 2015 Jun 9;15:65. doi: 10.1186/s12876-015-0297-z. BMC Gastroenterol. 2015. PMID: 26054761 Free PMC article.

7

Potential Role of MicroRNA-210 as Biomarker in Human Cancers Detection: A Meta-Analysis.

Lu J, Xie F, Geng L, Shen W, Sui C, Yang J. Lu J, et al. Biomed Res Int. 2015;2015:303987. doi: 10.1155/2015/303987. Epub 2015 Sep 13. Biomed Res Int. 2015. PMID: 26446394 Free PMC article. Review.

8

Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.

Sui CJ, Zhou YM, Shen WF, Dai BH, Lu JJ, Zhang MF, Yang JM. Sui CJ, et al. J Mol Med (Berl). 2016 Nov;94(11):1281-1296. doi: 10.1007/s00109-016-1442-z. Epub 2016 Jul 5. J Mol Med (Berl). 2016. PMID: 27380494

9

MicroRNA-147 suppresses human hepatocellular carcinoma proliferation migration and chemosensitivity by inhibiting HOXC6.

Sui CJ, Xu F, Shen WF, Dai BH, Lu JJ, Zhang MF, Yang JM. Sui CJ, et al. Am J Cancer Res. 2016 Dec 1;6(12):2787-2798. eCollection 2016. Am J Cancer Res. 2016. PMID: 28042500 Free PMC article.

10

LncRNA FOXD2-AS1 as a competitive endogenous RNA against miR-150-5p reverses resistance to sorafenib in hepatocellular carcinoma.

Sui C, Dong Z, Yang C, Zhang M, Dai B, Geng L, Lu J, Yang J, Xu M. Sui C, et al. Among authors: lu j. J Cell Mol Med. 2019 Sep;23(9):6024-6033. doi: 10.1111/jcmm.14465. Epub 2019 Jun 18. J Cell Mol Med. 2019. PMID: 31210410 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34,251 results

Search Page

Filters